Cristina Donini

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Geneva, IT (2014 - 2016)
Geneva, CH (2013 - 2018)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2013-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9914702 - Amine derivatives as potassium channel blockers (2018-03-13),

2. 9493451 - Amine derivatives as potassium channel blockers (2016-11-15),

3. 9308205 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyrdazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof (2016-04-12),

4. 9289427 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-hydrochloride salt and processes of manufacturing thereof (2016-03-22),

5. 8710058 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof (2014-04-29),

6. 8586599 - Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof (2013-11-19),

Title: Inventor Cristina Donini: Innovating in Potassium Channel Modulation

Introduction

Cristina Donini, an accomplished inventor based in Geneva, Switzerland, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of six patents, she specializes in developing innovative compounds aimed at the modulation of potassium channel activity. Her work holds promise in addressing various autoimmune and inflammatory diseases.

Latest Patents

Among her most notable patents are the innovative amine derivatives designed as potassium channel blockers. These compounds are particularly effective in modulating the activity of Kv1.3 channels found in T cells. The implications of this invention are far-reaching, as they relate directly to the treatment and prevention of serious health conditions, such as multiple sclerosis. Additionally, her inventions include methods for the preparation of pharmaceutical compositions containing these compounds, highlighting her comprehensive approach to medical innovation.

Career Highlights

Cristina has built an impressive career working with leading organizations in the pharmaceutical industry. She has been associated with Merck Patent GmbH, where she honed her skills in patent law and innovation, and Bionomics Inc., further enhancing her expertise in drug development and intellectual property. Her journey reflects a strong commitment to advancing health care solutions through innovative thinking.

Collaborations

Throughout her career, Cristina has collaborated with talented professionals such as Axel Becker and Clemens Kuehn. These partnerships have allowed her to exchange ideas and insights, driving forward the development of her groundbreaking inventions.

Conclusion

Cristina Donini stands out as a remarkable inventor whose work in potassium channel modulation is shaping the future of treatments for autoimmune and inflammatory diseases. Her dedication to innovation and collaboration continues to inspire new advancements in the pharmaceutical field, making her a significant figure in contemporary healthcare research.

This text is generated by artificial intelligence and may not be accurate.